Literature DB >> 33430819

Effectiveness of FIBEROPTIC phototherapy compared to conventional phototherapy in treating HYPERBILIRUBINEMIA amongst term neonates: a randomized controlled trial.

Helvi N Joel1, Deborah N Mchaile2,3, Rune N Philemon2,3, Ronald M Mbwasi2,3, Levina Msuya2,3.   

Abstract

BACKGROUND: Neonatal jaundice is one of the most common problems in neonates. Effective treatment of jaundice requires therapeutic intervention with high quality phototherapy. Over recent years, several studies reported fiberoptic phototherapy to be less effective than conventional phototherapy in term neonates. Our study aimed to compare the effectiveness of fiberoptic phototherapy with a larger illuminated area and higher irradiance to conventional phototherapy methods.
METHODS: This was a randomized controlled trial conducted at the Kilimanjaro Christian Medical Centre (KCMC). A total of 41 term neonates, less than 7 days of age with unconjugated hyperbilirubinemia were randomized. Thirteen (13) neonates were allocated to receive fiberoptic phototherapy, 13 to blue light conventional phototherapy and 15 to white light conventional phototherapy. Effectiveness was assessed by comparing the duration of phototherapy, bilirubin reduction rate and side effects of treatment. The data was analyzed with the independent t-test.
RESULTS: The mean overall bilirubin reduction rate was comparable in the fiberoptic phototherapy group (0.74%/h) and the blue light conventional phototherapy group (0.84%/h), with no statistically significant difference (p-value 0.124). However, white light conventional phototherapy had a significantly lower mean overall bilirubin reduction rate (0.29%/h) as compared to fiberoptic phototherapy (p-value < 0.001). The mean treatment duration of phototherapy was 69 h, 68 h and 90 h in the fiberoptic, blue light conventional and white light conventional phototherapy groups respectively. Side effects such as loose stool and skin rash were noted in some participants who received conventional phototherapy. No side effects of treatment were noted in the fiberoptic phototherapy group.
CONCLUSION: The effectiveness of fiberoptic PT and blue light conventional PT were comparable in terms of bilirubin reduction rate and treatment duration, whereas fiberoptic phototherapy was more effective than white light conventional PT, with a significantly higher bilirubin reduction rate and shorter treatment duration. Fiberoptic phototherapy may mitigate side effects caused by conventional phototherapy. TRIAL REGISTRATION: The Pan African Clinical Trial Registry, PACTR202004723570110 . Registered 22nd April 2020- Retrospectively registered.

Entities:  

Keywords:  Phototherapy; Unconjugated hyperbilirubinemia

Year:  2021        PMID: 33430819      PMCID: PMC7798326          DOI: 10.1186/s12887-020-02458-2

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


  15 in total

1.  Comparison of the efficacy of conventional special blue light phototherapy and fiberoptic phototherapy in the management of neonatal hyperbilirubinaemia.

Authors:  S U Sarici; F Alpay; B Unay; O Ozcan; E Gökçay
Journal:  Acta Paediatr       Date:  1999-11       Impact factor: 2.299

2.  Is the hour-specific bilirubin nomogram suitable for predicting hyperbilirubinemia.

Authors:  Bilgen Hülya; Ozek Eren; Topuzoglu Ahmet
Journal:  Indian J Pediatr       Date:  2008-05       Impact factor: 1.967

3.  Neonatal jaundice.

Authors:  M Jeffrey Maisels
Journal:  Pediatr Rev       Date:  2006-12

4.  Fiberoptic, conventional and combination phototherapy for treatment of nonhemolytic hyperbilirubinemia in neonates.

Authors:  S Al-Alaiyan
Journal:  Ann Saudi Med       Date:  1996-11       Impact factor: 1.526

5.  A clinical trial of fiberoptic phototherapy vs conventional phototherapy.

Authors:  P C Holtrop; K Madison; M J Maisels
Journal:  Am J Dis Child       Date:  1992-02

6.  Fibre optic versus conventional phototherapy for hyperbilirubinaemia in preterm infants.

Authors:  A H van Kaam; R H van Beek; J G Vergunst-van Keulen; J van der Heijden; N Lutz-Dettinger; W Hop; P J Sauer
Journal:  Eur J Pediatr       Date:  1998-02       Impact factor: 3.183

7.  ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017.

Authors:  Valerie J Flaherman; M Jeffrey Maisels
Journal:  Breastfeed Med       Date:  2017-04-10       Impact factor: 1.817

8.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

9.  BiliBlanket phototherapy system versus conventional phototherapy: a randomized controlled trial in preterm infants.

Authors:  S A Costello; J Nyikal; V Y Yu; P McCloud
Journal:  J Paediatr Child Health       Date:  1995-02       Impact factor: 1.954

10.  Light Emitting Diode (LED) Phototherapy versus Conventional Phototherapy in Neonatal Hyperbilirubinemia: A Single Blinded Randomized Control Trial from Coastal India.

Authors:  Sreesravya Gutta; Janardhan Shenoy; Sowmini P Kamath; Prasanna Mithra; B Shantharam Baliga; Muralikeshava Sarpangala; Mukund Srinivasan
Journal:  Biomed Res Int       Date:  2019-04-11       Impact factor: 3.411

View more
  1 in total

1.  Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Glen Lazarus; Jerrell Francie; Rosalina Dewi Roeslani; Siti Rizny Fitriana Saldi; Hanifah Oswari
Journal:  Ital J Pediatr       Date:  2022-10-17       Impact factor: 3.288

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.